AEMD Aethlon Medical, Inc.

NASDAQ
$2.83

Aethlon Medical, Inc. (AEMD) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $4.05 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -3.4% since its last earnings release on August 13, 2026.

Aethlon Medical Beat Consensus Estimates
Thursday, August 13, 2026 · 4:15 PM ET
Earnings Date
2nd Quarter, Sep 2026
Nov 12
Thursday · 4:15 PM ET
Earnings Whisper
-
vs ($4.05)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.83

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Aethlon Medical, Inc.

Aethlon Medical Inc manufactures medical devices to address unmet therapeutic needs in infectious disease, cancer and other life-threatening conditions. Its main product is the Aethlon Hemopurifier®.

Sector

Healthcare

Industry

Biotechnology